Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

SNTI Stock  USD 2.14  0.03  1.42%   
Under 51% of Senti Biosciences' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Senti Biosciences suggests that some traders are interested. Senti Biosciences' investing sentiment shows overall attitude of investors towards Senti Biosciences.
  
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Senti Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Senti Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Senti Biosciences Fundamental Analysis

We analyze Senti Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Senti Biosciences is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Senti Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Senti Biosciences stock to make a market-neutral strategy. Peer analysis of Senti Biosciences could also be used in its relative valuation, which is a method of valuing Senti Biosciences by comparing valuation metrics with similar companies.

Peers

Senti Biosciences Related Equities

RAPTRAPT Therapeutics   9.82   
0%
100.0%
MNPRMonopar Therapeutics   6.43   
0%
65.0%
CNTBConnect Biopharma   6.19   
0%
63.0%
LIPOLipella Pharmaceuticals   5.36   
0%
54.0%
MLYSMineralys Therapeutics,   4.71   
0%
47.0%
FHTXFoghorn Therapeutics   3.59   
0%
36.0%
CVKDCadrenal Therapeutics,   3.21   
0%
32.0%
XLOXilio Development   2.02   
0%
20.0%
TYRATyra Biosciences   1.78   
0%
18.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
17.0%
FENCFennec Pharmaceuticals   0.50   
5.0%
0%
SABSSAB Biotherapeutics   0.67   
6.0%
0%
CINGCingulate   3.67   
37.0%
0%

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance